SCHILLER-GANSHORN’s LFX Pulmonary Function Testing Software empowers pulmonary labs, hospitals, and respiratory clinics to streamline diagnostic workflows while improving the accuracy of lung function assessments. Designed as an all-in-one pulmonary function testing software for spirometry, oscillometry, diffusion testing, and body plethysmography, LFX enables clinicians to manage patient data, standardize respiratory testing, and generate ATS/ERS-compliant reports from a single integrated platform.
Furthermore, by combining advanced pulmonary diagnostics with efficient test data management and intuitive reporting tools, this lung function testing software helps healthcare providers detect respiratory conditions such as asthma and COPD earlier, monitor disease progression more effectively, and make faster, evidence-based treatment decisions—thereby ultimately improving clinical outcomes and operational efficiency across pulmonary function laboratories.
What Can LFX Pulmonary Function Testing Software Do for Your Clinical Workflow?
LFX is a versatile lung function testing software solution for hospitals and pulmonary clinics. Additionally, it provides all the necessary parameters to perform comprehensive, reliable, and accurate pulmonary function tests in adult, geriatric, and pediatric patients.
Its intuitive interface simplifies and enhances the process of conducting tests such as spirometry and oscillometry. Moreover, it features a statistical module that allows you to compare different visits of the same patient and a biological control module to ensure test quality. Of course, everything is in compliance with the quality standards set by the American Thoracic Society (ATS) and the European Respiratory Society (ERS).
The LFX software unifies our pulmonary function tests, spirometry and oscillometry into a single platform, providing specific functionalities for each. As a result, this makes it easier to manage and access relevant data. Now, let’s briefly explore how it works with each of them.
Spirometry Integration with LFX Pulmonary Function Testing Software: SpiroScout Ultrasonic Technology
SpiroScout harnesses the advantages of our SharpFlow (ultrasonic) technology to measure pulmonary flows and volumes, ensuring high precision, even with low flows. It also utilizes hygienic mouthpieces, ScoutTube, to prevent cross-contamination. Furthermore, it does not require warming up or calibration.
The LFX software allows you to measure FVC (Forced Vital Capacity), SVC (Slow Vital Capacity), and MVV (Maximum Voluntary Ventilation), among others. Additionally, it enables the comparison of a patient’s spirometry results to analyze the effectiveness of treatment. In particular, LFX includes three pediatric incentive features—candles, a paper airplane, and fish—to guide young patients during the maneuver.
Airway Oscillometry with LFX Pulmonary Function Testing Software: tremoflo® System
The Airway Oscillometry System, tremoflo®, measures airway resistance and reactance. How does it work? The patient breathes normally through a mouthpiece, and the tremoflo® generates small waves that travel through the airways. Subsequently, the device detects the returning waves and uses this information to calculate airway resistance and reactance.
In turn, LFX provides data for the resistance curve (central and peripheral airways) and the reactance curve (elasticity and peripheral airways), among other key data, combining them into the report along with spirometry.
PowerCube Body+: Advanced Body Plethysmography Integrated with Pulmonary Function Testing Software
PowerCube Body+ is the first body plethysmograph with SharpFlow (ultrasonic) flow measurement. It determines the patient’s exhaled gas in real time. Its measurement sensor requires no calibration and is resistance-free, making the maneuver more comfortable and easier for the patient.
- Additionally, LFX equips our plethysmograph with a wide range of standard tests: body plethysmography, airway resistance (Eff, Tot, 0.5, med, max), SVC, FVC (including flow-volume loops), and single-breath diffusion (optional). Furthermore, it also offers optional tests such as:
- Occlusion resistance (ROCC)
- Single-breath diffusion (DLCO)
- Real-time exhaled gas determination
- Real-time ATP–BTPS calculation
- Helium dilution
Â
PowerCube Diffusion+: Integrated DLCO Testing within Pulmonary Function Lab Software
SCHILLER-GANSHORN’s PowerCube Diffusion+ was the first diffusion system to feature ultrasound sensors, powered by our innovative SharpFlow measurement technology. Powercube Diffusion+ combines modern no calibration requiered ultrasonic sensors with fast proprietary technology sensors.
LFX software enhances the PowerCube Diffusion+ by providing respiratory specialists with advanced testing options, including:
- Single-breath diffusion (DLCO)
- Forced Vital Capacity (FVC), including flow-volume loops
- Slow Vital Capacity (SVC)
- Built-in calibration verification program
Key Benefits of LFX for Hospitals and Pulmonary Labs
- Complies with ATS/ERS quality criteria for determining test validity
- User-friendly
- Allows easy zooming in on any part of the respiratory curve
- Provides reports with modern and explanatory graphical elements
- Full Windows programming
- GDT (General Data Transfer)
- Network connectivity capability
- HL7 Interface
- DICOM solutions
Elevate Respiratory Diagnostics with an Integrated Lung Function Platform
LFX transforms complex pulmonary data into clear, clinically actionable insights. By integrating plethysmography, diffusion, spirometry, and oscillometry into one intuitive system, it streamlines workflows and gives your team a complete view of each patient’s respiratory status. As a result, the outcome is faster interpretation, greater diagnostic confidence, and more informed treatment decisions.
Empower your pulmonary lab with technology designed to improve efficiency, strengthen clinical outcomes, and maximize return on investment. Schedule a personalized demonstration today and see how your team can elevate respiratory diagnostics from the very first test.
ulmonary Function Testing Software for Pulmonologists and Respiratory Researchers
What is pulmonary function testing software used for in clinical pulmonology and respiratory research?
Pulmonary function testing software is used to acquire, analyze, and interpret lung function data obtained from diagnostic tests such as spirometry, body plethysmography, diffusion capacity (DLCO), and oscillometry. In clinical pulmonology, it supports the identification of obstructive and restrictive ventilatory patterns. Additionally, it enables standardized ATS/ERS-compliant reporting, thereby improving diagnostic consistency and facilitating longitudinal patient monitoring in both clinical and research settings.
How does pulmonary function testing software improve early detection of COPD, asthma, and interstitial lung disease (ILD)?
Pulmonary function testing software integrates multiple respiratory parameters into a unified analytical platform. As a result, clinicians can detect early airflow limitation, lung volume restriction, and impaired gas exchange from the initial assessment. Furthermore, it allows healthcare providers to compare historical spirometry and diffusion test data over time, thereby supporting disease progression tracking and evaluation of treatment effectiveness in COPD, asthma, and ILD.
Can pulmonary function testing software support longitudinal lung function monitoring in clinical trials?
Yes, pulmonary function testing software plays a critical role in respiratory clinical research. For instance, it enables standardized pulmonary test execution across study populations and facilitates consistent spirometry and DLCO data acquisition in multicenter trials. Moreover, it supports longitudinal lung function monitoring by allowing researchers to evaluate trends in airway resistance, lung volumes, and diffusion capacity throughout the duration of a study.
Why is ATS/ERS compliance important in pulmonary function testing software?
ATS/ERS compliance ensures that pulmonary function tests are conducted according to internationally recognized quality standards. Consequently, this improves test reproducibility and diagnostic reliability in both clinical and research environments. In addition, standardized spirometry and diffusion testing protocols minimize variability, thereby strengthening evidence-based clinical decision-making.